Elements Solutions for Retreatment Analysis supports the follow-up and decision-making process and facilitates retreatment planning for patients with multiple brain metastases. With Elements Retreatment Review, you can generate an overview of all prior treatments and current patient status—helping to plan optimal retreatment strategies.
Make the optimum treatment decisions
Align all prior treatment information with new follow-up scans to assess the current status of your patient. Benefit from a comprehensive, color-coded overview of new and previously treated metastases that will support your decision-making for potential retreatment for patients with new metastases.
Benefit from advanced AI-powered tumor segmentation1
Integrate Elements AI Tumor Segmentation for fast and easy delineation, supporting the review of recurring or new lesions in Elements Retreatment Review. This new AI-based method can segment supported cranial tumors on contrast-enhanced T1-weighted MRI scans.
1Not yet commercially available in several countries. Please contact your sales representative.
Automatically consider previous PTVs during new arc placement
The Retreatment Review solution supports treatment planning for new and recurring lesions by automatically integrating prior PTV information during arc placement in the new dose plan.
